Citi Initiates Coverage on Solid Biosciences Inc. (SLDB) with ‘Buy’ Rating and $14 PT
Citi initiated coverage on Solid Biosciences Inc. (NASDAQ:SLDB) with a ‘Buy’ rating, setting its price target at $14 on June 26, 2025.
Solid Biosciences Inc. (SLDB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 11,833,539 | $73,012,936 | -1% | 2.11% |
| 2. | Siren L.L.C. Raymond Debbane | 7,415,905 | $45,756,134 | 1.79% | |
| 3. | RA Capital Management Peter Kolchinsky | 5,811,423 | $35,856,480 | +1% | 0.44% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 4,000,000 | $24,680,000 | -41% | 0.04% |
| 5. | Vestal Point Capital Ryan Wilder | 2,975,000 | $18,355,750 | +98% | 0.83% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.34 | 1,860 | $9,924.40 | 2,960 | 2025-03-11 | Filing | |
| $4.03 | 1,000,000 | $4,030,000.00 | 5,034,582 | 2025-02-19 | Filing | |
| $4.03 | 5,000,000 | $20,150,000.00 | 11,833,539 | 2025-02-19 | Filing | |
| $7.56 | 252,545 | $1,909,240.20 | 4,248,084 | 2025-02-18 | Filing | |
| $7.67 | 1,100 | $8,441.62 | 1,100 | 2024-06-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.12 | 3,278 | $13,505.36 | 95,412 | 2025-11-10 | Filing | |
| $5.96 | 2,895 | $17,254.20 | 33,819 | 2025-10-20 | Filing | |
| $3.96 | 3,079 | $12,192.84 | 19,281 | 2025-02-14 | Filing | |
| $3.96 | 3,256 | $12,893.76 | 22,812 | 2025-02-14 | Filing | |
| $3.96 | 3,164 | $12,529.44 | 32,250 | 2025-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,911,669 | $48,814,998 | 3.24% | |
| 2. | 4,725,118 | $29,153,978 | 0% | |
| 3. | 3,083,850 | $19,027,355 | 0% | |
| 4. | 2,914,127 | $17,980,164 | 0% | |
| 5. | 1,599,232 | $9,867,261 | 0% |
News See All
7 Best Stocks to Invest in for a Quick Return
Going after quick returns in stock investing often means capitalizing on strong trends before they cool off.
14 Stocks With Heavy Insider Buying In 2024
Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months to come.
Hedge Funds Have Never Been This Bullish On Solid Biosciences Inc. (SLDB)
In this article we will check out the progression of hedge fund sentiment towards Solid Biosciences Inc. (NASDAQ:SLDB) and determine whether it is a good investment right now.
Is SLDB A Good Stock To Buy Now?
In this article we will take a look at whether hedge funds think Solid Biosciences Inc. (NASDAQ:SLDB) is a good investment right now.
Solid Biosciences Inc. (SLDB): Hedge Fund Sentiment Unchanged
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Solid Biosciences Inc. (SLDB) Going to Burn These Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Here's What Hedge Funds Think About Solid Biosciences Inc. (SLDB)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...
Here's What Hedge Funds Think About About Solid Biosciences Inc. (SLDB)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
This Biotech Investor's Picks Returned 31% in Q1; Here Are Its New Bets
Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns.
Hedge Fund Resource Center Billionaire Hedge Funds
